Melvin Strickland v. CVS Pharmacy, Inc.; Missouri CVS Pharmacy, LLC

CourtDistrict Court, W.D. Missouri
DecidedFebruary 20, 2026
Docket4:25-cv-00278
StatusUnknown

This text of Melvin Strickland v. CVS Pharmacy, Inc.; Missouri CVS Pharmacy, LLC (Melvin Strickland v. CVS Pharmacy, Inc.; Missouri CVS Pharmacy, LLC) is published on Counsel Stack Legal Research, covering District Court, W.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Melvin Strickland v. CVS Pharmacy, Inc.; Missouri CVS Pharmacy, LLC, (W.D. Mo. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MISSOURI WESTERN DIVISION MELVIN STRICKLAND, ) ) Plaintiff, ) ) v. ) Case No. 4:25-cv-00278-RK ) CVS PHARMACY, INC.; MISSOURI CVS ) PHARMACY, LLC, ) ) Defendants. ) ORDER Plaintiff Melvin Strickland brings one count of medical negligence related to erroneous fulfillments of a prescription throughout 2020. Before the Court is Defendants CVS Pharmacy, Inc. and Missouri CVS Pharmacy, LLC’s (collectively, “CVS”) motion for summary judgment. (Doc. 33.) The motion is fully briefed. After careful consideration and review, the Court ORDERS that CVS’s motion for summary judgment is DENIED. Background On or about August 24, 2018, Plaintiff’s primary care nurse prescribed him Duloxetine 30 milligram (“mg”) capsules, to be taken one capsule by mouth daily (30 mg total). (Doc. 35 at ¶ 5.) Plaintiff filled his prescription at CVS Pharmacy #5655. (Id. at ¶ 6.) In 2018 or 2019, Plaintiff’s nurse practitioner increased his Duloxetine dosage to 60 mg capsules, to be taken one capsule by mouth once daily (60 mg total). (Id. at ¶ 7.) Plaintiff continued filling his prescription at CVS Pharmacy #5655. (Id. at ¶ 8.) On or about November 5, 2019, Plaintiff’s nurse practitioner increased his Duloxetine dosage again, this time to 30 mg capsules, to be taken three capsules by mouth daily (90 mg total). (Id. at ¶ 10.) Plaintiff had the prescription filled at CVS Pharmacy #5655 and followed the instructions provided on the prescription label—take three (3) capsules daily. (Id. at ¶ 11.) On or about January 23, 2020, CVS Pharmacy #5655 dispensed a prescription for Duloxetine 60 mg capsules to Plaintiff, with instructions to take one capsule daily. (Id. at ¶ 12.) Approximately one week later, CVS Pharmacy #5655 also dispensed Duloxetine 30 mg capsules to Plaintiff with instructions to take three capsules daily. (Id. at ¶ 13.) After receiving both prescriptions, Plaintiff ingested one 60 mg capsule and three 30 mg capsules each day, in accordance with CVS’s instructions, resulting in a total daily dosage of 150 mg of Duloxetine. (Id. at ¶ 14.) Plaintiff continued receiving refills of both prescriptions throughout 2020—his last bottle of 60 mg capsules was filled on December 30, 2020. (Doc. 34-2 at ¶ 3.) On January 5, 2021, Plaintiff informed his nurse practitioner that he had been taking one 60 mg capsule and three 30 mg capsules of Duloxetine daily, resulting in a total daily dosage of 150 mg of Duloxetine for the previous year. (Doc. 35 at ¶ 15.) Plaintiff’s nurse practitioner did not intend for Plaintiff to ingest more than 90 mg of Duloxetine per day. (Id. at ¶ 16.) Plaintiff alleges that during 2020, he experienced adverse health effects that his nurse practitioner later attributed to the overdosing of Duloxetine, opining that the medication “caus[ed] or contribut[ed] to” those health issues. (Doc. 1-1 at ¶ 27.) On January 20, 2022, Plaintiff filed a medical negligence action against CVS in the Circuit Court of Clay County, Missouri. (Doc. 35 at ¶ 18.) Summons was issued on January 24, 2022. (Doc. 34-3 at 1.) On April 19, 2022, Plaintiff requested and was granted a ninety-day extension of time to file the required healthcare provider affidavit pursuant to § 538.225, RSMo.1 (Id. at ¶ 21.) Plaintiff never filed the affidavit or effectuated service of process on CVS in this case. (Id. at ¶¶ 19-23.) On May 14, 2024, the circuit court scheduled a dismissal hearing for July 25, 2024. (Doc. 37 at ¶ 28.) Two days before the dismissal hearing, on July 23, 2024, Plaintiff voluntarily dismissed the 2022 case. (Id. at ¶ 24.) On December 30, 2024, Plaintiff refiled his medical negligence claim against CVS in the same circuit court. (Id. at ¶ 25.) CVS was served with the Complaint on March 19, 2025, and Plaintiff filed a healthcare provider affidavit on March 20, 2025. (Id. at ¶ 26; Doc. 34-4 at 2.) CVS removed the case to the United States District Court for the Western District of Missouri. CVS moves for summary judgment, arguing that Missouri’s two-year statute of limitations for medical negligence claims bars Plaintiff’s claim.

1 Section 538.225 requires that a medical malpractice plaintiff submit, “no later than ninety days after the filing of the petition,” an affidavit stating that the plaintiff has obtained the written opinion of a legally qualified health care provider stating that the defendant health care provider committed medical malpractice that directly caused or contributed to the damages claimed by the plaintiff. Mo. Rev. Stat. § 538.225.1, 5. Failure to do so requires that the court “upon motion of any party, dismiss the action . . . without prejudice.” § 538.225.6. Legal Standard Federal Rule of Civil Procedure 56 governs a motion for summary judgment. “A party may move for summary judgment, identifying each claim or defense—or the part of each claim or defense—on which summary judgment is sought.” Fed. R. Civ. P. 56(a). “Summary judgment is required if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. Ins. Co. v. Great Am. Ins. Co., 893 F.3d 1098, 1102 (8th Cir. 2018) (internal quotation marks omitted). “A moving party is ‘entitled to judgment as a matter of law’ if the nonmoving party fails to make a sufficient showing of an essential element of a claim with respect to which it has the burden of proof.” Woodsmith Pub. Co. v. Meredith Corp., 904 F.2d 1244, 1247 (8th Cir. 1990) (quoting Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986)). “In considering a motion for summary judgment, the court does not weigh the evidence, make credibility determinations, or attempt to discern the truth of any factual issue.” Morris v. City of Chillicothe, 512 F.3d 1013, 1018 (8th Cir. 2008). Instead, the Court views the evidence “in the light most favorable to the nonmoving party and giv[es] the nonmoving party the benefit of all reasonable inferences.” Fed. Ins. Co., 893 F.3d at 1102 (internal quotation marks omitted). Discussion CVS’s statute of limitations argument concerns several Missouri statutes. The applicable statute of limitations for medical negligence actions is two years. Mo. Rev. Stat. § 516.105.1. CVS argues that the statute of limitations expired on January 23, 2022, two years after the first allegedly erroneous fulfillment of 60 mg capsules (i.e., on January 23, 2020, following the nurse practitioner’s November 5, 2019 prescriptions for three 30 mg capsules for a total of 90 mg). Even assuming that CVS is correct,2 Plaintiff’s original action, filed on January 20, 2022, was timely filed. Under Missouri’s medical malpractice statute of limitations, a plaintiff that does not serve a medical malpractice defendant before the two-year statute of limitations expires must do so

2 According to Plaintiff, he “arguably had until January 5, 2023 to file his original lawsuit since he did not discover that he was overdosing on Duloxetine until January 5, 2021.” (Doc. 35 at 1-2.) However, the Court notes that “Missouri courts have consistently declined to adopt a ‘discovery’ exception to section 516.205[.]” C.H. v. Infertility Ctr. of Saint Louis, 681 S.W.3d 579, 584 n.6 (Mo. Ct. App. 2023). Plaintiff does allege that CVS continued to over-dispense Duloxetine to him until December 30, 2020.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Woodsmith Publishing Co. v. Meredith Corporation
904 F.2d 1244 (Eighth Circuit, 1990)
Morris v. City of Chillicothe
512 F.3d 1013 (Eighth Circuit, 2008)
Ostermueller v. Potter
868 S.W.2d 110 (Supreme Court of Missouri, 1993)
Bailey v. Innovative Management & Investment, Inc.
890 S.W.2d 648 (Supreme Court of Missouri, 1995)
Korman v. Lefholz
890 S.W.2d 771 (Missouri Court of Appeals, 1995)
State ex rel. Weigman v. Moentmann
942 S.W.2d 441 (Missouri Court of Appeals, 1997)
Zinke v. Orskog
422 S.W.3d 422 (Missouri Court of Appeals, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Melvin Strickland v. CVS Pharmacy, Inc.; Missouri CVS Pharmacy, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/melvin-strickland-v-cvs-pharmacy-inc-missouri-cvs-pharmacy-llc-mowd-2026.